Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future.

Muaed Jamal AlomarAli M TawfiqNageeb HassanSubish Palaian

Published in: Therapeutic advances in drug safety (2020)

To strengthen medicine safety monitoring and reporting by healthcare professionals, more awareness among health professionals and innovative strategies are needed. Integrating the genetic data of patients can be beneficial in predicting adverse effects, therefore avoiding them and enhancing safe prescribing and dispensing by healthcare professionals.

Keyphrases

adverse drug
current status
electronic health record
end stage renal disease
emergency department
ejection fraction
newly diagnosed
public health
drug induced
pulmonary embolism
big data
machine learning
genome wide
deep learning